Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06153238 |
|---|---|
| Brief Title: | A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma |
| First Submitted : | October 11, 2023 |
| First Submitted that Met QC Criteria : | November 22, 2023 |
| First Posted : | December 1, 2023 |
| Last Update Submitted that Met QC Criteria : | March 26, 2024 |
| Last Update Posted : | March 27, 2024 |